Trial Profile
A COMPARISON OF LONG-ACTING INJECTABLE MEDICATIONS FOR SCHIZOPHRENIA.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Feb 2024
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Haloperidol decanoate
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms ACLAIMS
- 27 Nov 2018 Results assessing age-wise Efficacy Failure published in the Journal of Clinical Psychiatry
- 06 Sep 2016 Status changed from active, no longer recruiting to completed.
- 07 Apr 2015 According to the planned end date changed from 1 May 2014 to 1 Jul 2016.